Gastroenterology covers the digestive system. It focuses on diagnosing, treating, and managing conditions of the stomach, intestines, liver, and pancreas.

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

Diagnosis and Evaluation

Cirrhosis

Diagnosing cirrhosis involves a multi-modal approach aimed at confirming the presence of advanced fibrosis, assessing the remaining synthetic function of the liver, and screening for the dangerous complications of portal hypertension. Because the disease can be asymptomatic for decades, incidental findings on routine blood work or imaging often trigger the initial investigation. At Liv Hospital, we utilize a comprehensive diagnostic pathway that combines non-invasive elastography, advanced imaging, and functional serology to accurately stage the disease without defaulting to invasive biopsies unless absolutely necessary.

Icon LIV Hospital

Blood Laboratory Assessment

image 5 70 LIV Hospital

Routine blood tests provide the foundational data for assessing liver injury and function.

  • Aminotransferases (AST and ALT):
    These liver enzymes indicate inflammation and cell death. In cirrhosis, they may be elevated, but paradoxically, they can also be normal or low because there is not enough healthy liver tissue left to release enzymes. An AST level that is higher than the ALT level often suggests an alcohol-related cause.
  • Alkaline Phosphatase (ALP) and GGT:
    Elevations in these enzymes suggest blockage of the bile ducts or cholestasis, common in conditions like Primary Biliary Cholangitis (PBC).
  • Bilirubin:
    This measures the liver’s ability to clear waste. Elevated total and conjugated bilirubin levels indicate hepatocellular dysfunction and lead to jaundice.
  • Albumin:
    Albumin is a protein made exclusively by the liver. Low levels (hypoalbuminemia) are a specific marker of reduced synthetic capability and contribute to edema.
  • Prothrombin Time (PT) and INR:
    The liver produces clotting factors. A prolonged PT or elevated INR (International Normalized Ratio) indicates that the liver is failing to synthesize these factors efficiently. This is a critical marker of disease severity.
  • Platelet Count:
    Thrombocytopenia (low platelet count) is often the earliest and most sensitive blood indicator of cirrhosis. It is caused by hypersplenism, where the enlarged spleen sequesters and destroys platelets due to portal hypertension.
  • Hyponatremia: Low sodium levels are common in advanced cirrhosis due to fluid retention and hemodynamic changes, serving as a poor prognostic sign.
Icon 1 LIV Hospital

Non-Invasive Fibrosis Assessment

Cirrhosis

Modern hepatology has moved away from biopsy as the sole method of diagnosis, favoring non-invasive technologies.

  • Transient Elastography (FibroScan):
    This is the standard of care for staging fibrosis. It uses a specialized ultrasound probe to send a mechanical shear wave through the liver. The velocity of the wave is measured; the faster the wave travels, the stiffer the liver. A result measured in kilopascals (kPa) allows doctors to grade fibrosis from F0 to F4 (cirrhosis) instantly and painlessly.
  • Shear Wave Elastography:
    Integrated into standard ultrasound machines, this technique provides a real-time heat map of liver stiffness, offering anatomical context alongside stiffness measurements.
  • Serum Fibrosis Panels: Tests like the FIB-4 Index or APRI Score utilize common lab values (age, AST, ALT, platelets) to statistically calculate the probability of fibrosis, helping to triage patients who need further testing.

Diagnostic Imaging

Imaging is crucial for visualizing the morphology of the liver and detecting complications.

  • Abdominal Ultrasound:
    This is the first-line screening tool. A cirrhotic liver typically appears shrunken (atrophic), nodular (bumpy surface), and echogenic (bright). Ultrasound is also the primary tool for detecting splenomegaly and ascites, and for screening for liver cancer (HCC).
  • Doppler Ultrasound:
    This assesses the direction and speed of blood flow in the portal vein and hepatic arteries. It can detect reversal of flow (hepatofugal flow) or clots (portal vein thrombosis).
  • Computed Tomography (CT) Scan:
    A multiphase CT scan provides detailed anatomical information. It can visualize varices, map the collateral circulation, and characterize liver masses with high precision. It often shows a “corkscrew” appearance of the hepatic arteries.
  • Magnetic Resonance Imaging (MRI): MRI is superior for characterizing indeterminate liver nodules and assessing the biliary tree (MRCP). It avoids radiation exposure and is highly sensitive for hepatocellular carcinoma.

Liver Biopsy

image_16
  • The Histological Gold Standard:
    While less common now, percutaneous or transjugular liver biopsy remains the definitive test if non-invasive methods are inconclusive or if the etiology is unclear (e.g., suspected autoimmune hepatitis).
  • Transjugular Approach:
    In patients with ascites or clotting problems, the biopsy is performed via the jugular vein in the neck to minimize bleeding risk. This also allows for the direct measurement of portal pressure (HVPG).

Clinical Severity Scores

image_8

Prognostic models are calculated to determine the stage of disease and transplant priority.

  • Child-Turcotte-Pugh (CTP) Score:
    This classifies cirrhosis into Class A (compensated), Class B (significant compromise), and Class C (decompensated). It uses five variables: Bilirubin, Albumin, INR, presence of Ascites, and presence of Encephalopathy.
  • MELD Score (Model for End-Stage Liver Disease): This score (ranging from 6 to 40) is calculated using Bilirubin, INR, and Creatinine (and sometimes Sodium). It predicts 3-month mortality and is the primary metric used to allocate organs for liver transplantation. A higher MELD score indicates more severe disease and higher transplant priority.

Endoscopic Evaluation

  • Esophagogastroduodenoscopy (EGD):
    Because variceal bleeding is a major cause of death, all patients newly diagnosed with cirrhosis undergo an upper endoscopy. A camera is passed down the throat to inspect the esophagus and stomach for dilated veins (varices). If high-risk varices are found, preventive treatment is initiated immediately.

30 Years of
Excellence

Trusted Worldwide

With patients from across the globe, we bring over three decades of medical

We're Here to Help.
Get in Touch.

Send us all your questions or requests, and our expert team will assist you.

Doctors

FREQUENTLY ASKED QUESTIONS

Does a FibroScan hurt?

No, FibroScan is a completely painless, non-invasive procedure. It feels like a gentle flicker or tap on the skin over the liver. It takes about 10 to 15 minutes and requires no sedation.

Varices (swollen veins) in the esophagus cause no pain or symptoms until they burst. An endoscopy is the only way to see them before a catastrophic bleed occurs, allowing doctors to treat them preventatively.

The MELD score is a statistical number that tells doctors how urgently you need a liver transplant. It reflects how likely a patient is to survive the next three months without a new liver. It is recalculated regularly as lab values change.

Blood tests can strongly suggest cirrhosis (e.g., low platelets combined with high INR), but they are not definitive proof on their own. They must be combined with imaging (like FibroScan or Ultrasound) or biopsy for a confirmed diagnosis.

Surveillance is lifelong. Typically, you will need blood tests and a liver ultrasound (to screen for cancer) every 6 months. Endoscopy frequency depends on whether varices are found and how large they are.

Spine Hospital of Louisiana

Let's Talk About Your Health

BUT WAIT, THERE'S MORE...

Leave your phone number and our medical team will call you back to discuss your healthcare needs and answer all your questions.

Let's Talk About Your Health

Contact Us to Get Information!

Contact

How helpful was it?

helpful
helpful
helpful
Your Comparison List (you must select at least 2 packages)